These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New drugs for rheumatoid arthritis. Messori A; Santarlasci B; Vaiani M N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436 [No Abstract] [Full Text] [Related]
8. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy. Nagashima T; Minota S J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792 [No Abstract] [Full Text] [Related]
9. [Pharmacotherapy of rheumatoid arthritis in the era of genetically engineered biological preparations]. Nasonov EL Ter Arkh; 2007; 79(5):5-8. PubMed ID: 17672066 [No Abstract] [Full Text] [Related]
10. Anti-TNF-alpha therapies: they are all the same (aren't they?). Mpofu S; Fatima F; Moots RJ Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736 [No Abstract] [Full Text] [Related]
11. Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis? Gabriel SE Arthritis Rheum; 2008 Mar; 58(3):637-40. PubMed ID: 18311805 [No Abstract] [Full Text] [Related]
12. Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Ledingham J; Deighton C; Rheumatology (Oxford); 2005 Feb; 44(2):157-63. PubMed ID: 15637039 [No Abstract] [Full Text] [Related]
13. New drugs for rheumatoid arthritis. Olsen NJ; Stein CM N Engl J Med; 2004 May; 350(21):2167-79. PubMed ID: 15152062 [No Abstract] [Full Text] [Related]
14. [TNF-alpha antagonist in rheumatoid arthritis. Joint destruction can be controlled]. MMW Fortschr Med; 2003 Oct; 145(41):46. PubMed ID: 14655484 [No Abstract] [Full Text] [Related]
15. When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step? Smolen JS; Weinblatt ME Ann Rheum Dis; 2008 Nov; 67(11):1497-8. PubMed ID: 18854512 [No Abstract] [Full Text] [Related]
16. Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis. Gonzalez-Gay MA; Garcia-Unzueta MT; Berja A; Vazquez-Rodriguez TR; Gonzalez-Juanatey C; de Matias JM; Martin J; Dessein PH; Llorca J Ann Rheum Dis; 2008 Nov; 67(11):1644-6. PubMed ID: 18854515 [No Abstract] [Full Text] [Related]
17. Differentiating the efficacy of tumor necrosis factor inhibitors. Haraoui B J Rheumatol Suppl; 2005 Mar; 74():3-7. PubMed ID: 15742457 [TBL] [Abstract][Full Text] [Related]
18. Recombinant DNA product for rheumatoid arthritis. FDA Consum; 2003; 37(2):5. PubMed ID: 12715755 [No Abstract] [Full Text] [Related]
19. Adalimumab therapy in rheumatoid arthritis. Keystone E; Haraoui B Rheum Dis Clin North Am; 2004 May; 30(2):349-64, vii. PubMed ID: 15172045 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-α inhibitor-induced antiglomerular basement membrane antibody disease in a patient with rheumatoid arthritis. Nishimura K; Saegusa J; Kawano S; Morinobu A J Rheumatol; 2012 Sep; 39(9):1904-5. PubMed ID: 22942311 [No Abstract] [Full Text] [Related] [Next] [New Search]